ELP4

elongator acetyltransferase complex subunit 4, the group of Elongator acetyltransferase complex

Basic information

Region (hg38): 11:31509755-31790324

Previous symbols: [ "C11orf19" ]

Links

ENSG00000109911NCBI:26610OMIM:606985HGNC:1171Uniprot:Q96EB1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • aniridia 2 (Limited), mode of inheritance: AD
  • aniridia 2 (Strong), mode of inheritance: AD
  • aniridia 1 (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Aniridia 2ADOphthalmologic; PharmacogenomicIndividuals with PAX6 related eye anomalies (including due to cis-regulatory variants in ELP4) may be recognizable, but some may also be at high risk of developing glaucoma; Agents that may contribute to glaucoma should be avoidedOphthalmologic24290376
The condition has been reported as caused by an intronic variant in a PAX6 cis-regulatory element

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ELP4 gene.

  • Aniridia 1 (2 variants)
  • not provided (2 variants)
  • Aniridia 1;Irido-corneo-trabecular dysgenesis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELP4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
7
clinvar
2
clinvar
9
missense
27
clinvar
5
clinvar
5
clinvar
37
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
2
non coding
5
clinvar
2
clinvar
58
clinvar
27
clinvar
18
clinvar
110
Total 5 2 86 40 25

Variants in ELP4

This is a list of pathogenic ClinVar variants found in the ELP4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-31509799-A-C ELP4-related disorder Likely benign (Apr 16, 2018)771804
11-31509801-C-T not specified Uncertain significance (Nov 13, 2023)1174681
11-31509815-G-A not specified Likely benign (Mar 12, 2024)3088519
11-31509847-C-G Likely benign (Mar 07, 2023)2887867
11-31509866-A-G Uncertain significance (Feb 09, 2023)2797726
11-31509876-G-T not specified Uncertain significance (Jan 04, 2024)3088524
11-31509877-G-T Uncertain significance (May 05, 2023)2696817
11-31509911-G-T Uncertain significance (Oct 19, 2022)2901384
11-31509949-G-T ELP4-related disorder Likely benign (Apr 29, 2022)3029785
11-31510019-G-A Benign (Apr 20, 2023)2851004
11-31520069-C-T ELP4-related disorder Likely benign (May 22, 2019)3039471
11-31520077-C-G not specified Uncertain significance (Oct 17, 2023)3088518
11-31539674-A-G Cognitive impairment;Global developmental delay;Seizure Likely pathogenic (-)1328942
11-31539685-TC-T Autism spectrum disorder association (-)996731
11-31539728-A-G not specified Likely benign (Dec 13, 2022)2391737
11-31539740-T-C Benign (Jan 29, 2024)772330
11-31594824-G-T not specified Uncertain significance (Dec 13, 2023)3088520
11-31594876-G-A not specified Uncertain significance (Sep 27, 2023)2517420
11-31594882-A-C Uncertain significance (Dec 14, 2023)2712116
11-31603771-G-A not specified Uncertain significance (Dec 14, 2023)3088521
11-31603790-G-T ELP4-related disorder Uncertain significance (Sep 17, 2024)3347720
11-31603795-G-A Uncertain significance (Oct 26, 2023)2985438
11-31603802-A-G Uncertain significance (Apr 10, 2023)2715618
11-31603826-C-A ELP4-related disorder Benign/Likely benign (Jan 01, 2024)707203
11-31603860-A-T Benign (Oct 28, 2022)2801587

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ELP4protein_codingprotein_codingENST00000350638 10274250
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.23e-70.8141247750221247970.0000881
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3002422291.060.00001142715
Missense in Polyphen9181.9131.1109986
Synonymous-0.4568983.71.060.00000399848
Loss of Function1.461421.30.6589.80e-7282

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001980.000198
Ashkenazi Jewish0.000.00
East Asian0.00005850.0000556
Finnish0.00004640.0000464
European (Non-Finnish)0.0001070.000106
Middle Eastern0.00005850.0000556
South Asian0.00003310.0000327
Other0.0001790.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as subunit of the RNA polymerase II elongator complex, which is a histone acetyltransferase component of the RNA polymerase II (Pol II) holoenzyme and is involved in transcriptional elongation. Elongator may play a role in chromatin remodeling and is involved in acetylation of histones H3 and probably H4. {ECO:0000269|PubMed:11714725, ECO:0000269|PubMed:11818576, ECO:0000269|PubMed:16713582}.;
Pathway
Mesodermal Commitment Pathway;Chromatin modifying enzymes;HATs acetylate histones;Chromatin organization (Consensus)

Recessive Scores

pRec
0.111

Intolerance Scores

loftool
0.588
rvis_EVS
0.86
rvis_percentile_EVS
88.74

Haploinsufficiency Scores

pHI
0.120
hipred
Y
hipred_score
0.605
ghis
0.457

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.330

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Elp4
Phenotype

Gene ontology

Biological process
tRNA wobble uridine modification;regulation of transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;regulation of protein kinase activity
Cellular component
nucleoplasm;cytoplasm;transcription elongation factor complex;Elongator holoenzyme complex
Molecular function
RNA polymerase II complex binding;protein binding;phosphorylase kinase regulator activity